Analysis of tissue ABH antigens in superficial bladder tumours.
The determination of ABH blood group antigens for the prognosis of superficial bladder tumours was evaluated. A total of 114 cases of superficial bladder tumours were studied, and all cases were treated by transurethral resection (TUR). The 5-year recurrence rate was 42%. The ABH antigenicity provided more useful information than the grade in predicting recurrence of the tumours. The period from the initial TUR till the first recurrence in antigen-negative tumours was 17.5 months, which was shorter, though not significantly, than the corresponding period in antigen-positive tumours of 25.2 months. In addition, the presence or absence of isoantigens of tumours having two or more recurrences was examined individually.
Department of Urology, Kinki University School of Medicine, Osaka, Japan.
H
H
Tsujihashi
H
H
Matsuda
S
S
Uejima
T
T
Akiyama
T
T
Kurita
D000017:ABO Blood-Group System; D002278:Carcinoma in Situ / Q000097:blood* / Q000453:epidemiology; D002295:Carcinoma, Transitional Cell / Q000097:blood* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D011379:Prognosis; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000453:epidemiology
D000017:ABO Blood-Group System